| | |
| Legal status | |
|---|---|
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C20H27FN2O |
| Molar mass | 330.447 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
FAB-144 is an indazole-based synthetic cannabinoid that is presumed to be a potent agonist of the CB1 receptor [1] and has been sold online as a designer drug. [2] It is the indazole analogue of XLR-11.
Sweden's public health agency suggested classifying FAB-144 as a hazardous substance on November 10, 2014. [3]